Chemotherapy

Pancreatic Cancer: Review of the Current and Investigational Drug Landscape

Kevin H. Pang, PharmD; Valassia Antigone Theocharides; Yuxi Lei; Shivani K. Rana, BS; Richa K. Rana, BS; Mark H. Mansour; Meghana K. Ganjam; Jennifer Ahmed, PharmD

Neoadjuvant FOLFIRINOX Therapy for a Patient with Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Hemodialysis: Case Report

Mark E. Jao, PharmD; Kathyrn S. Lee, PharmD, BCOP; Shannon Jeong, PharmD; Reid Nakagawa, PharmD; Eve-Michelle Segal, PharmD, BCOP; Stacey Cohen, MD

Impact of Pharmacist Telephone Follow-Up on Chemotherapy-Induced Nausea and Vomiting

Jenny McCabe, PharmD; Amanda Al-Bahou, PharmD, BCOP; Leann Koontz, PharmD, BCPS, BCOP; Linda Linderbeck, PharmD, BCOP; Michael Verbosky, PharmD, BCPS; Michelle Prieto, PharmD

Pharmacist-Led Oral Chemotherapy Monitoring Pilot Study and Assessment of Patient-Reported Outcomes and Adherence

Abstract #CR09

Evaluation of the Safety and Potential Time-Savings of Subcutaneous Rituximab Administration in a Single Cancer Center

Ashka Patel, PharmD, BCOP; Chirag Patel, MS; Caroline M. Mejías-De Jesús, PharmD, BCOP

Dosing Chemotherapy in Obese Patients, Still Not Answered

By Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant

Katelyn A. Zink, PharmD, BCOP; Jill Stein, PharmD, BCOP; Patrick Ten Eyck, MS, PhD; Meredith Ginn, PharmD, BCOP

Urine Alkalinization and Methotrexate Clearance: Are These Key to Safe Administration of High-Dose Methotrexate?

Joseph Bubalo, PharmD, BCPS, BCOP

Efficacy of an Enteral Urine Alkalinization Strategy During Intravenous Sodium Bicarbonate Shortage in Patients with Cancer Receiving High-Dose Methotrexate

Christopher Sinoimeri, PharmD; Matthew Lei, PharmD, BCOP; Stephanie Monaco, PharmD, BCOP; Uvette Lou, PharmD, BCOP